Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

NCT02706249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Venous Thormboembolism

Interventions

DRUG: Enoxaparin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]